Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Lars van der Veen"'
Autor:
Claudia Kalla, German Ott, Francesca Finotello, Karolina Niewola-Staszkowska, Giusy Di Conza, Michael Lahn, Lars van der Veen, Julia Schüler, Roger Falkenstern-Ge, Joanna Kopecka, Chiara Riganti
Publikováno v:
Translational Oncology, Vol 43, Iss , Pp 101857- (2024)
Targeting aberrantly expressed kinases in malignant pleural mesothelioma (MPM) is a promising therapeutic strategy. We here investigated the effect of the novel and highly selective Phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib (IOA
Externí odkaz:
https://doaj.org/article/29e97e2677864d378073466d49ffbb29
Autor:
Silvia Novello, Chiara Riganti, Luisella Righi, Fabrizio Tabbò, Lars van der Veen, Michael Lahn, Giusy Di Conza, Giorgio Scagliotti, Laurence Neff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/bda83d6324b24941ba90ba45ab95c59d
Autor:
Carmelo Carlo-Stella, Michael Lahn, Tracey Hammett, Lars van der Veen, Rebeca Zorrilla, Catherine Pickering, Armando Santoro
Publikováno v:
HemaSphere, Vol 7, p e17216e2 (2023)
Externí odkaz:
https://doaj.org/article/fd8cb46b7d54416ebe426764dd5d2a37
Autor:
Zoe Johnson, Alan Carruthers, Elisa Matas-Rico, Marcel Deken, Karolina Niewola, Ragini Medhi, Anne Cheasty, Olivier Peyruchaud, Amy Fraser, Pritom Shah, Wouter Moolenaar, Lars van der Veen, Michael Lahn
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/7356959f73434226863f4f8bb9dcd86b
Autor:
Zoë Johnson, Chiara Tarantelli, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola-Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni, Lars van der Veen, Giusy Di Conza
Publikováno v:
Cancer Research Communications. 3:576-591
PI3K delta (PI3Kδ) inhibitors are used to treat lymphomas but safety concerns and limited target selectivity curbed their clinical usefulness. PI3Kδ inhibition in solid tumors has recently emerged as a potential novel anticancer therapy through the
Autor:
Giusy Di Conza, Lars van der Veen, Francesco Bertoni, Denis Migliorini, Mathias Wenes, Dominique Perrin, Michael Lahn, Karolina Niewola-Staszkowska, Andrea Rinaldi, Sara Napoli, Tyzoon Nomanbhoy, Pritom Shah, Amy Fraser, Filippo Spriano, Luciano Cascione, Elisa Civanelli, Chiara Tarantelli, Zoë Johnson
Target engagement kinase tree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e48f330c4be9c625cf4c94237f10cc
https://doi.org/10.1158/2767-9764.22634434
https://doi.org/10.1158/2767-9764.22634434
Autor:
Giusy Di Conza, Lars van der Veen, Francesco Bertoni, Denis Migliorini, Mathias Wenes, Dominique Perrin, Michael Lahn, Karolina Niewola-Staszkowska, Andrea Rinaldi, Sara Napoli, Tyzoon Nomanbhoy, Pritom Shah, Amy Fraser, Filippo Spriano, Luciano Cascione, Elisa Civanelli, Chiara Tarantelli, Zoë Johnson
Table summarizing the IC50 values derived from previous published experiments performed with IOA-244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6859857a49b6c3e892790e8a544721ec
https://doi.org/10.1158/2767-9764.22634425.v1
https://doi.org/10.1158/2767-9764.22634425.v1
Autor:
Giusy Di Conza, Lars van der Veen, Francesco Bertoni, Denis Migliorini, Mathias Wenes, Dominique Perrin, Michael Lahn, Karolina Niewola-Staszkowska, Andrea Rinaldi, Sara Napoli, Tyzoon Nomanbhoy, Pritom Shah, Amy Fraser, Filippo Spriano, Luciano Cascione, Elisa Civanelli, Chiara Tarantelli, Zoë Johnson
PI3K delta (PI3Kδ) inhibitors are used to treat lymphomas but safety concerns and limited target selectivity curbed their clinical usefulness. PI3Kδ inhibition in solid tumors has recently emerged as a potential novel anticancer therapy through the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4902879218007350c0bf6163104f3caa
https://doi.org/10.1158/2767-9764.c.6551246
https://doi.org/10.1158/2767-9764.c.6551246
Autor:
Giusy Di Conza, Lars van der Veen, Francesco Bertoni, Denis Migliorini, Mathias Wenes, Dominique Perrin, Michael Lahn, Karolina Niewola-Staszkowska, Andrea Rinaldi, Sara Napoli, Tyzoon Nomanbhoy, Pritom Shah, Amy Fraser, Filippo Spriano, Luciano Cascione, Elisa Civanelli, Chiara Tarantelli, Zoë Johnson
Correlation analysis of PI3Kd levels and the response to IOA-244 and Idelalisib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff549e13245e67d824071968b3d33de
https://doi.org/10.1158/2767-9764.22546793
https://doi.org/10.1158/2767-9764.22546793
Autor:
Giusy Di Conza, Lars van der Veen, Francesco Bertoni, Denis Migliorini, Mathias Wenes, Dominique Perrin, Michael Lahn, Karolina Niewola-Staszkowska, Andrea Rinaldi, Sara Napoli, Tyzoon Nomanbhoy, Pritom Shah, Amy Fraser, Filippo Spriano, Luciano Cascione, Elisa Civanelli, Chiara Tarantelli, Zoë Johnson
Phosphoinositide 3-kinase delta (PI3Kd) inhibitors are used to treat lymphomas but safety concerns and limited target selectivity curbed their clinical usefulness. PI3Kd inhibition in solid tumors has recently emerged as a potential novel anti-cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1aeb158052be023ce9ba699df9885fc
https://doi.org/10.1158/2767-9764.c.6551246.v1
https://doi.org/10.1158/2767-9764.c.6551246.v1